Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients with Advanced NMSC

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This current registry study will analyze real-world data to address questions about disease characteristics and treatment patterns in NMSC patients based on the European NMSC-Registry. The overall objective is to describe characteristics, management and treatment outcomes for patients presenting with advanced NMSC (cSCC/BCC) or HR-cSCC in routine clinical practice, independent of treatments used across different European regions.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients aged ≥18 years at index date

• Patients documented in the European NMSC-registry fulfilling EMR quality standard

• Patients with resected HR-cSCC (Cohort 1) receiving only postoperative radiotherapy or watchful waiting OR Patients with advanced cSCC who are not candidates for curative surgery/radiation in routine clinical practice (Cohort 2) OR Patients with advanced BCC who are not candidates for curative surgery/radiation in routine clinical practice (Cohort 3)

Locations
Other Locations
Belgium
UZ (Universitair Ziekenhuis) Brüssel
RECRUITING
Brussels
Contact Information
Primary
Alexandra Hansen
alexandra.hansen@eumelareg.org
+493037026901
Time Frame
Start Date: 2023-06-30
Estimated Completion Date: 2027-12
Participants
Target number of participants: 1300
Treatments
resected HR-cSCC
Patients with resected HR-cSCC (Cohort 1) receiving only postoperative radiotherapy or watchful waiting
advanced cSCC
Patients with advanced cSCC who are not candidates for curative surgery/radiation in routine clinical practice (Cohort 2)
advanced BCC
Patients with advanced BCC who are not candidates for curative surgery/radiation in routine clinical practice (Cohort 3)
Related Therapeutic Areas
Sponsors
Leads: EuMelaReg gGmbH

This content was sourced from clinicaltrials.gov